Hyperprolinemia Type 1

Watchlist
Retrieved
2021-01-23
Source
Trials
Genes
Drugs

A rare disorder of proline metabolism characterized biochemically by markedly elevated levels of proline in plasma and urine due to deficiency of proline oxidase. The reported clinical phenotype ranges from asymptomatic to variable neurologic and psychiatric manifestations (including global developmental delay, seizures, autistic features, and hyperactivity).